Bifidobacterium longum as an oral delivery system of endostatin for gene therapy on solid liver cancer
- 26 November 2004
- journal article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 12 (2) , 133-140
Abstract
To overcome difficulties that hampered widespread application of a specific delivery system in cancer gene therapy and to inhibit the growth of solid liver cancer, we utilized a strain of Bifidobacterium longum as a delivery system to transport an endostatin gene that can inhibit growth of tumor. The B. longum strain with the endostatin gene (B. longum-En) was taken orally by tumor-bearing nude mice through drencher preparation. The results showed that B. longum-En could strongly inhibit the growth of solid liver tumor in nude mice and prolong the survival time of tumor-bearing nude mice. Furthermore, tumor growth was inhibited more efficiently when the B. longum-En treatment included selenium. Enriching the B. longum-En treatment with selenium improves the activity of NK and T cells and stimulates the activity of IL-2 and TNF- in BALB/c mice. These results suggest that B. longum may be a highly specific and efficient vector for transporting anticancer genes in cancer gene therapy.Keywords
This publication has 15 references indexed in Scilit:
- Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growthCancer Gene Therapy, 2003
- Combination Angiostatin and Endostatin Gene Transfer Induces Synergistic Antiangiogenic Activity in Vitro and Antitumor Efficacy in Leukemia and Solid Tumors in MiceMolecular Therapy, 2001
- Local endostatin treatment of gliomas administered by microencapsulated producer cellsNature Biotechnology, 2001
- Serum endostatin levels in patients with hepatocellular carcinomaAnnals of Oncology, 2000
- Bifidobacterium longum as a delivery system for cancer gene therapy: Selective localization and growth in hypoxic tumorsCancer Gene Therapy, 2000
- HepG2 hepatocytes express IFN-γ, TNF-α, TGF-β, M-CSF, oncostatin-M, ICAM-1, IL-4, IL-5, IL-7, IL-10, IL-11, IL-12 and IL-6 receptor genes in vitroCritical Care, 1998
- Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor GrowthCell, 1997
- Complement Subcomponent C1q Modulation of TNF-α Binding to L929 Cells for Enhanced TNF-Mediated CytotoxicityScandinavian Journal of Immunology, 1996
- A convenient and reproducible method to genetically transform bacteria of the genus BifidobacteriumMicrobiology, 1996
- Enhancement of Immune Response in Peyer's Patch Cells Cultured with Bifidobacterium breveJournal of Dairy Science, 1991